Miprobes: Tests for the future

About Us

MiProbes develops novel, instrument-free diagnostics and diagnostic tools to identify pathogens in patient samples.

With our innovative platform technology, we identify novel biomarkers of pathogens and design protein and DNA-based diagnostic tools which allow for specific detection of pathogens in order to inform doctors and veterinarians about the correct antibiotics to prescribe.

DIAGNOSIS OF BACTERIAL INFECTION IS SLOW AND COMPLEX

Delayed Results

Traditional approaches take 3-5 days to identify bacteria. Patients must wait several days for their results.

Misdiagnosis

Infections are commonly misdiagnosed and the wrong antibiotics are given, contributing to the rising antibiotic resistance problem

Constraints

Resources are limited, laboratories reach capacity and end up with a back-log of tests waiting to be processed.

Breakthrough bacterial detection technology

MiProbes has a platform technology that is used to identify novel biomarkers of pathogens and develop diagnostics tools to identify pathogens.

Our product is a reagent that can be freeze-dried on to paper. It produces a result in less than 1 hour, costs one-third as much as traditional bacterial culture, does not require any instrumentation and matches the quality of the gold standards.

Rapid Detection
Our results are in less than 60 minutes. Faster results save lives.

Easy-to-use
Color change indicates diagnosis and requires no hardware or software for analysis.

Mobile
No hardware is required to do testing. Our tests can be deployed at point-of-care and outside of labs and hospitals.

The Team

MiProbes is led by synthetic biology and in-vitro diagnostics experts. By collaborating with leading research institutions and companies and with our expert panel of advisors, MiProbes is committed to developing diagnostics to improve human and animal health.